ADAMTS13 and thrombotic thrombocytopenic purpura: The patient's ADAMTS13 activity drawn on the day of admission ultimately resulted as <5%, and screening for ADAMTS13 inhibitor was positive, confirming a diagnosis of acquired TTP.